EBNA-1 a potential biomarker in Multiple Sclerosis (MS)

Scientists have discovered a blood test that could help predict the course of multiple sclerosis (MS), and indicate who is likely to develop the condition after a first MS-like attack.

The results of the study suggest that differing antibody levels produced in response to the common virus Epstein Barr Virus (EBV), may predict the course of MS. 


The authors of the study concluded that EBNA-1 is a potential biomarker in MS that might be useful in predicting disability and progression.